KBC Group’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,876
Closed -$30K 1508
2023
Q1
$30K Hold
1,876
﹤0.01% 1466
2022
Q4
$33K Hold
1,876
﹤0.01% 1466
2022
Q3
$37K Hold
1,876
﹤0.01% 1452
2022
Q2
$37K Buy
+1,876
New +$41.9K ﹤0.01% 1475
2015
Q3
Sell
-7,645
Closed -$132K 1372
2015
Q2
$132K Buy
+7,645
New +$128K ﹤0.01% 1201
2014
Q1
Sell
-8,164
Closed -$136K 1333
2013
Q4
$136K Sell
8,164
-2,749
-25% -$42.9K ﹤0.01% 1087
2013
Q3
$178K Buy
+10,913
New +$170K ﹤0.01% 1001

Other funds holding PETS

KBC Group's PETS Position: Q2 2023 in Review

KBC Group sold out of PetMed Express (PETS) in Q2 2023, closing a stake of 1,876 shares — an estimated $30K sold.

KBC Group first reported a position in PETS in Q3 2013 and held it in 7 quarters. The position peaked at $178K in Q3 2013. 149 funds tracked by Wall St. Rank hold PETS as of Q2 2023.

  • KBC Group reported no remaining PetMed Express position as of Q2 2023 after selling out during the quarter.
  • KBC Group sold 1,876 PetMed Express shares in Q2 2023, an estimated $30K.
  • KBC Group first reported a position in PetMed Express in Q3 2013 and held it in 7 quarters.
  • KBC Group's PetMed Express position peaked at $178K in Q3 2013.
  • 149 funds tracked by Wall St. Rank held PetMed Express as of Q2 2023.

Based on KBC Group's 13F filing for Q2 2023, filed 28 Jul 2023.